股本结构
单位：万股
| 公告日期 | 2025-08-26 | 2025-08-15 | 2025-08-11 | 2025-02-05 | 2024-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| 证券总股本 | 708.86 | 708.46 | 708.32 | 704.40 | 698.90 | 452.41 |
| 普通股本 | 708.86 | 708.46 | 708.32 | 704.40 | 698.90 | 452.41 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-08-22 | 2025-06-30 | 2025-03-31 | 2025-01-31 | 2024-12-20 | 2024-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-08-26 | 708.86 | 未披露 | 定期报告 | 2025-08-22 |
| 2025-08-15 | 708.46 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-08-11 | 708.32 | 未披露 |
更多>>
From September 30, 2024 to March 31, 2025
Private placement - common shares
Pre-funded warrants exercised
Options exercised
Warrants exercised
RSUs exercised
|
2025-03-31 |
| 2025-02-05 | 704.40 | 未披露 | 定期报告 | 2025-01-31 |
| 2024-12-31 | 698.90 | 未披露 | 定期报告 | 2024-12-20 |
| 2024-11-12 | 694.85 | 未披露 | 定期报告 | 2024-11-04 |
| 2024-12-31 | 452.41 | 未披露 |
更多>>
From September 30, 2023 to September 30, 2024
Private placement - common shares
Pre funded warrant exercise
RSUs exercised
|
2024-09-30 |
| 2024-02-13 | 446.38 | 未披露 | 定期报告 | 2023-12-31 |
| 2023-12-29 | 446.37 | 未披露 | 定期报告 | 2023-12-22 |
| 2023-12-29 | 446.38 | 未披露 |
更多>>
From September 30, 2022 to September 30, 2023
Private placement - common shares
Warrants exercised
RSUs exercised
|
2023-09-30 |
| 2023-08-15 | 377.21 | 未披露 | 定期报告 | 2023-08-14 |
| 2023-07-12 | 377.21 | 未披露 |
更多>>
Bright Minds Biosciences Inc. will consolidate its common shares on a five (5) to one (1) basis (the “Consolidation”).
|
2023-07-14 |
| 2023-05-15 | 1886.04 | 未披露 | 定期报告 | 2023-03-31 |
| 2022-12-29 | 1871.04 | 未披露 | 定期报告 | 2022-12-28 |
| 2022-12-29 | 1759.24 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-08-30 | 1520.99 | 未披露 | 定期报告 | 2022-08-30 |
| 2022-08-29 | 1235.19 | 未披露 | 定期报告 | 2022-08-25 |
| 2022-08-15 | 1211.19 | 未披露 | 定期报告 | 2022-08-12 |
| 2022-05-16 | 1187.19 | 未披露 | 定期报告 | 2022-05-16 |
| 2022-03-02 | 1184.69 | 未披露 | 定期报告 | 2022-02-15 |
| 2022-02-15 | 1183.44 | 未披露 | 定期报告 | 2022-02-14 |
| 2021-12-29 | 1184.69 | 未披露 | 定期报告 | 2021-12-23 |
| 2021-09-17 | 1183.44 | 未披露 | 定期报告 | 2021-11-08 |
From September 30, 2024 to March 31, 2025
Private placement - common shares
Pre-funded warrants exercised
Options exercised
Warrants exercised
RSUs exercised
From September 30, 2023 to September 30, 2024
Private placement - common shares
Pre funded warrant exercise
RSUs exercised
From September 30, 2022 to September 30, 2023
Private placement - common shares
Warrants exercised
RSUs exercised
Bright Minds Biosciences Inc. will consolidate its common shares on a five (5) to one (1) basis (the “Consolidation”).